Drawing for VUEBLU

USPTO serial 98019606

VUEBLU

Reviewed by CopyMark Law Group

Reg. 7910823Status 700Registered
Filing date
Status date
Registration date
Aug 26, 2025
Examiner
LADZEKPO, ASHIMADI DELA KOSHI
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VUEBLU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Pickerill

John Pickerill FREDRIKSON & BYRON, P.A.60 SOUTH 6TH STREET, SUITE 1500MINNEAPOLIS, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the enhancing of adenomatous, cancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), including those with previous history of polyps at prior colonoscopy, patients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes in the nature of surgical dyes; pharmaceutical preparations for use in the endoscopic diagnostic evaluation; pharmaceutical compositions for use in endoscopy; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy; dyes for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy in the nature of surgical dyesACTIVE—
010Medical devices for use in chromoendoscopy and endoscopy procedures of the gastrointestinal tract; medical devices to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; medical instruments to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; medical devices for enhancing visualization during chromoendoscopy, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy procedures; medical devices for introducing compositions containing dye into the human body for pharmaceutical, medical, surgical and medical diagnostic purposes; medical devices made with dye for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions for pharmaceutical, medical, surgical and medical diagnostic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 26, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 10, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 10, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 4, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2025XAECEXAMINER'S AMENDMENT ENTERED—
May 7, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 7, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
May 7, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
May 5, 2025XAECEXAMINER'S AMENDMENT ENTERED—
May 5, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 5, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
May 5, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 7, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2024DOCKASSIGNED TO EXAMINER—
Oct 1, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2024ALIEASSIGNED TO LIE—
Jun 7, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 25, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 25, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Mar 25, 2024CNSLSUSPENSION LETTER WRITTEN—
Feb 21, 2024DOCKASSIGNED TO EXAMINER—
Jun 30, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 29, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance